Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Income Statement
Earnings Waterfall
Tonghua Dongbao Pharmaceutical Co Ltd
Revenue
|
3.1B
CNY
|
Cost of Revenue
|
-621.5m
CNY
|
Gross Profit
|
2.5B
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
1.3B
CNY
|
Other Expenses
|
-104.2m
CNY
|
Net Income
|
1.2B
CNY
|
Income Statement
Tonghua Dongbao Pharmaceutical Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 204
N/A
|
1 265
+5%
|
1 308
+3%
|
1 369
+5%
|
1 451
+6%
|
1 521
+5%
|
1 576
+4%
|
1 661
+5%
|
1 669
+0%
|
1 722
+3%
|
1 780
+3%
|
1 909
+7%
|
2 040
+7%
|
2 155
+6%
|
2 332
+8%
|
2 414
+4%
|
2 545
+5%
|
2 699
+6%
|
2 827
+5%
|
2 701
-4%
|
2 693
0%
|
2 688
0%
|
2 664
-1%
|
2 741
+3%
|
2 777
+1%
|
2 781
+0%
|
2 817
+1%
|
2 906
+3%
|
2 892
0%
|
2 997
+4%
|
3 080
+3%
|
3 162
+3%
|
3 268
+3%
|
3 332
+2%
|
2 993
-10%
|
2 912
-3%
|
2 778
-5%
|
2 556
-8%
|
2 757
+8%
|
2 771
+0%
|
3 075
+11%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(394)
|
(421)
|
(415)
|
(433)
|
(453)
|
(462)
|
(468)
|
(463)
|
(420)
|
(411)
|
(414)
|
(469)
|
(509)
|
(551)
|
(608)
|
(603)
|
(655)
|
(720)
|
(753)
|
(771)
|
(754)
|
(750)
|
(740)
|
(720)
|
(729)
|
(708)
|
(687)
|
(679)
|
(583)
|
(592)
|
(583)
|
(565)
|
(584)
|
(599)
|
(603)
|
(613)
|
(628)
|
(630)
|
(630)
|
(623)
|
(621)
|
|
Gross Profit |
811
N/A
|
844
+4%
|
894
+6%
|
936
+5%
|
999
+7%
|
1 059
+6%
|
1 109
+5%
|
1 198
+8%
|
1 250
+4%
|
1 311
+5%
|
1 365
+4%
|
1 440
+5%
|
1 531
+6%
|
1 604
+5%
|
1 724
+7%
|
1 811
+5%
|
1 890
+4%
|
1 980
+5%
|
2 074
+5%
|
1 931
-7%
|
1 939
+0%
|
1 938
0%
|
1 924
-1%
|
2 021
+5%
|
2 048
+1%
|
2 073
+1%
|
2 130
+3%
|
2 227
+5%
|
2 309
+4%
|
2 405
+4%
|
2 497
+4%
|
2 597
+4%
|
2 684
+3%
|
2 734
+2%
|
2 390
-13%
|
2 299
-4%
|
2 150
-6%
|
1 926
-10%
|
2 127
+10%
|
2 148
+1%
|
2 454
+14%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(592)
|
(610)
|
(635)
|
(687)
|
(648)
|
(656)
|
(657)
|
(673)
|
(684)
|
(697)
|
(688)
|
(684)
|
(732)
|
(757)
|
(828)
|
(858)
|
(907)
|
(929)
|
(945)
|
(922)
|
(954)
|
(947)
|
(958)
|
(1 045)
|
(1 106)
|
(1 126)
|
(1 174)
|
(1 213)
|
(1 163)
|
(1 195)
|
(1 235)
|
(1 307)
|
(1 425)
|
(1 429)
|
(1 409)
|
(1 345)
|
(1 264)
|
(1 215)
|
(1 198)
|
(1 174)
|
(1 182)
|
|
Selling, General & Administrative |
(584)
|
(602)
|
(628)
|
(679)
|
(563)
|
(641)
|
(641)
|
(658)
|
(596)
|
(690)
|
(681)
|
(677)
|
(608)
|
(747)
|
(815)
|
(821)
|
(755)
|
(897)
|
(936)
|
(914)
|
(831)
|
(894)
|
(869)
|
(960)
|
(984)
|
(1 041)
|
(1 076)
|
(1 105)
|
(1 049)
|
(1 122)
|
(1 157)
|
(1 214)
|
(1 222)
|
(1 260)
|
(1 248)
|
(1 174)
|
(1 082)
|
(1 063)
|
(1 056)
|
(1 063)
|
(1 040)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(51)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
(66)
|
0
|
0
|
(22)
|
(97)
|
0
|
0
|
(27)
|
(69)
|
(71)
|
(87)
|
(81)
|
(45)
|
(81)
|
(94)
|
(104)
|
(77)
|
(123)
|
(130)
|
(143)
|
(141)
|
(158)
|
(152)
|
(161)
|
(107)
|
(145)
|
(132)
|
(100)
|
(69)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(34)
|
0
|
0
|
0
|
(35)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
(79)
|
0
|
0
|
0
|
(79)
|
0
|
0
|
0
|
(83)
|
0
|
0
|
0
|
(74)
|
0
|
0
|
0
|
(79)
|
0
|
0
|
0
|
(77)
|
|
Other Operating Expenses |
(8)
|
(8)
|
(8)
|
(8)
|
(0)
|
(16)
|
(16)
|
(16)
|
(1)
|
(7)
|
(7)
|
(7)
|
(0)
|
(10)
|
(13)
|
(15)
|
3
|
(32)
|
(9)
|
19
|
25
|
19
|
(2)
|
(4)
|
2
|
(6)
|
(4)
|
(4)
|
46
|
50
|
51
|
51
|
12
|
(10)
|
(9)
|
(10)
|
5
|
(6)
|
(10)
|
(11)
|
4
|
|
Operating Income |
219
N/A
|
234
+7%
|
258
+10%
|
250
-3%
|
350
+40%
|
403
+15%
|
452
+12%
|
525
+16%
|
565
+8%
|
614
+9%
|
677
+10%
|
757
+12%
|
800
+6%
|
847
+6%
|
895
+6%
|
953
+6%
|
984
+3%
|
1 051
+7%
|
1 130
+7%
|
1 009
-11%
|
984
-2%
|
991
+1%
|
966
-2%
|
976
+1%
|
943
-3%
|
948
+1%
|
956
+1%
|
1 013
+6%
|
1 146
+13%
|
1 210
+6%
|
1 262
+4%
|
1 290
+2%
|
1 258
-2%
|
1 305
+4%
|
981
-25%
|
955
-3%
|
886
-7%
|
711
-20%
|
930
+31%
|
974
+5%
|
1 272
+31%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(12)
|
(12)
|
(15)
|
(11)
|
(21)
|
(25)
|
9
|
5
|
(31)
|
(1)
|
(44)
|
(50)
|
(61)
|
(50)
|
(40)
|
(35)
|
3
|
11
|
7
|
21
|
8
|
1
|
10
|
14
|
26
|
33
|
36
|
42
|
40
|
42
|
60
|
237
|
77
|
823
|
1 169
|
994
|
71
|
427
|
78
|
91
|
100
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
35
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
(1)
|
0
|
0
|
0
|
(6)
|
1
|
11
|
14
|
214
|
(2)
|
(13)
|
(16)
|
872
|
0
|
0
|
0
|
(7)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
|
Total Other Income |
5
|
6
|
6
|
8
|
3
|
(3)
|
(5)
|
(7)
|
1
|
1
|
4
|
6
|
20
|
19
|
12
|
9
|
(13)
|
(16)
|
(19)
|
(21)
|
(15)
|
(15)
|
(10)
|
(15)
|
(15)
|
(22)
|
(23)
|
(15)
|
(10)
|
(68)
|
(67)
|
(67)
|
(4)
|
(13)
|
(13)
|
(10)
|
1
|
3
|
3
|
1
|
4
|
|
Pre-Tax Income |
212
N/A
|
228
+8%
|
249
+9%
|
246
-1%
|
324
+32%
|
375
+16%
|
456
+22%
|
523
+15%
|
571
+9%
|
614
+8%
|
637
+4%
|
712
+12%
|
759
+7%
|
815
+7%
|
868
+6%
|
926
+7%
|
973
+5%
|
1 047
+8%
|
1 118
+7%
|
1 009
-10%
|
978
-3%
|
978
+0%
|
970
-1%
|
978
+1%
|
953
-3%
|
959
+1%
|
970
+1%
|
1 041
+7%
|
1 108
+6%
|
1 185
+7%
|
1 266
+7%
|
1 475
+16%
|
1 534
+4%
|
2 112
+38%
|
2 124
+1%
|
1 922
-10%
|
1 830
-5%
|
1 141
-38%
|
1 010
-11%
|
1 065
+5%
|
1 366
+28%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(32)
|
(34)
|
(37)
|
(34)
|
(47)
|
(57)
|
(66)
|
(77)
|
(81)
|
(85)
|
(94)
|
(110)
|
(120)
|
(127)
|
(133)
|
(139)
|
(133)
|
(143)
|
(153)
|
(131)
|
(139)
|
(139)
|
(135)
|
(139)
|
(143)
|
(145)
|
(150)
|
(164)
|
(178)
|
(195)
|
(202)
|
(230)
|
(226)
|
(309)
|
(307)
|
(279)
|
(248)
|
(140)
|
(126)
|
(126)
|
(198)
|
|
Income from Continuing Operations |
179
|
194
|
212
|
212
|
277
|
318
|
390
|
446
|
490
|
530
|
543
|
603
|
639
|
688
|
735
|
788
|
840
|
903
|
965
|
878
|
839
|
839
|
834
|
839
|
810
|
813
|
820
|
877
|
930
|
990
|
1 064
|
1 245
|
1 309
|
1 803
|
1 817
|
1 644
|
1 582
|
1 001
|
884
|
940
|
1 168
|
|
Income to Minority Interest |
4
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
(4)
|
(3)
|
(3)
|
(2)
|
(0)
|
(1)
|
(0)
|
0
|
2
|
2
|
1
|
2
|
(0)
|
(1)
|
(1)
|
(3)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Net Income (Common) |
184
N/A
|
198
+8%
|
216
+9%
|
215
0%
|
280
+30%
|
322
+15%
|
393
+22%
|
450
+14%
|
493
+10%
|
533
+8%
|
546
+2%
|
604
+11%
|
641
+6%
|
690
+8%
|
736
+7%
|
789
+7%
|
837
+6%
|
900
+8%
|
963
+7%
|
876
-9%
|
839
-4%
|
838
0%
|
834
-1%
|
839
+1%
|
811
-3%
|
815
+0%
|
821
+1%
|
879
+7%
|
930
+6%
|
989
+6%
|
1 062
+7%
|
1 242
+17%
|
1 308
+5%
|
1 803
+38%
|
1 817
+1%
|
1 643
-10%
|
1 582
-4%
|
1 001
-37%
|
884
-12%
|
939
+6%
|
1 168
+24%
|
|
EPS (Diluted) |
0.1
N/A
|
0.11
+10%
|
0.12
+9%
|
0.12
N/A
|
0.14
+17%
|
0.17
+21%
|
0.2
+18%
|
0.22
+10%
|
0.25
+14%
|
0.26
+4%
|
0.27
+4%
|
0.3
+11%
|
0.32
+7%
|
0.34
+6%
|
0.36
+6%
|
0.39
+8%
|
0.41
+5%
|
0.44
+7%
|
0.47
+7%
|
0.42
-11%
|
0.41
-2%
|
0.4
-2%
|
0.4
N/A
|
0.41
+2%
|
0.4
-2%
|
0.41
+2%
|
0.41
N/A
|
0.43
+5%
|
0.46
+7%
|
0.49
+7%
|
0.52
+6%
|
0.61
+17%
|
0.64
+5%
|
0.88
+38%
|
0.91
+3%
|
0.82
-10%
|
0.79
-4%
|
0.5
-37%
|
0.44
-12%
|
0.47
+7%
|
0.59
+26%
|